Search

Issue
Title
Authors
Mouse Induced Glioma-Initiating Cell Models and Therapeutic Targets
Kondo T.
Polyphenols Counteract Tumor Cell Chemoresistance Conferred by Multidrug Resistance Proteins
Michalak K., Wesolowska O.
Curcumin as an Adjuvant to Breast Cancer Treatment
Kumar P., Kadakol A., Shasthrula P., Mundhe N., Jamdade V., Barua C., Gaikwad A.
Hypersensitivity to Aurora Kinase Inhibitors in Cells Resistant against Platinum- Containing Anticancer Agents
Akiyama M., Izumi H., Wang K., Yamaguchi T., Kuma A., Kitamura N., Harada Y., Oya R., Yamaguchi K., Iwai Y., Kohno K.
Cytoskeletal Alterations that Confer Resistance to Anti-tubulin Chemotherapeutics
Kanakkanthara A., H. Teesdale-Spittle P., H. Miller J.
The Gut-To-Breast Connection - Interdependence of Sterols and Sphingolipids in Multidrug Resistance and Breast Cancer Therapy
Spassieva S., Bieberich E.
Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells
Wang R., Chang C., Chen C., Liu K., Chao J.
Tumor-associated Macrophages Mediate Gefitinib Resistance in Lung Cancer through HGF/c-met Signaling Pathway
Tang X., Chen Y., Jiao D., Liu X., Chen J., Liu Y., Jiang C., Chen Q.
Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review
Sidhu J., Singla R., Mayank , Jaitak V.
Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance
Karthikeyan S., Hoti S.
miR-1271 Regulates Cisplatin Resistance of Human Gastric Cancer Cell Lines by Targeting IGF1R, IRS1, mTOR, and BCL2
Yang M., Shan X., Zhou X., Qiu T., Zhu W., Ding Y., Shu Y., Liu P.
Doxorubicin-Loaded Nanoparticles: New Advances in Breast Cancer Therapy
Prados J., Melguizo C., Ortiz R., Velez C., J. Alvarez P., L. Arias J., A. Ruiz M., Gallardo V., Aranega A.
Angiogenesis in Glioblastoma Multiforme: Navigating the Maze
G. Linkous A., M. Yazlovitskaya E.
Fresh Platinum Complexes with Promising Antitumor Activity
Wang X.
Synthesis and Biological Evaluation of Novel Antifolate Analogs as Potential Anticancer Treatment
F. Stoicescu D., Rotaru M.
Acetogenins as Potential Anticancer Agents
Mangal M., Khan M., Agarwal S.
Recent Trends of Chalcones Potentialities as Antiproliferative and Antiresistance Agents
Winter E., Locatelli C., Pietro A., Creczynski-Pasa T.
The Indolylcoumarin COUFIN Exhibits Potent Activity Against Renal Carcinoma Cells without Affecting Hematopoietic System
Champelovier P., Barbier P., Daras E., Douillard S., Toussaint B., Persoon V., Curri V., Peyrot V., Combes S.
Colon Adenocarcinoma Multidrug Resistance Reverted by Euphorbia Diterpenes: Structure-Activity Relationships and Pharmacophore Modeling
Reis M., J. Ferreira R., Serly J., Duarte N., M. Madureira A., J. V. A. Santos D., Molnar J., U. Ferreira M.
Combination Therapy for the Treatment of Pancreatic Cancer
Greenhalf W., Thomas A.
A Better Platinum-Based Anticancer Drug Yet to Come?
Olszewski U., Hamilton G.
Propofol and Sevoflurane Alleviate Malignant Biological Behavior and Cisplatin Resistance of Xuanwei Lung Adenocarcinoma by Modulating the Wnt/β-catenin Pathway and PI3K/AKT Pathway
Quan Y., Li S., Wang Y., Liu G., Lv Z., Wang Z.
Peroxisome Proliferator-Activated Receptors and their Ligands in Cancer Drug- Resistance: Opportunity or Challenge
Yousefi B., Zarghami N., Samadi N., Majidinia M.
Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance
Li S., Zhang W., Yin X., Xing S., Xie H., Cao Z., Zhao B.
Physiological Modulation Approaches to Improve Cancer Chemotherapy : A Review
Kumar R., Kaur M., Silakari O.
Targeting Tumor Ubiquitin-Proteasome Pathway with Polyphenols for Chemosensitization
Shen M., Hang Chan T., Ping Dou Q.
BRAF as a Target for Cancer Therapy
Dienstmann R., Tabernero J.
Lung Cancer Stem Cells as a Target for Therapy
Gorelik E., Lokshin A., Levina V.
Potential of Nanomedicines as an Alternative for the Treatment of Colorectal Cancer - A Review
Nicolau Costa K., Barros L.A., da Silva Soares I.L., Oshiro-Junior J.A.
Molecular Mechanisms of Anti-cancer Activities of β-elemene: Targeting Hallmarks of Cancer
Jiang S., Ling C., Li W., Jiang H., Zhi Q., Jiang M.
Effectiveness of Two Novel Anionic and Cationic Platinum Complexes in the Treatment of Osteosarcoma
Igarashi K., Yamamoto N., Hayashi K., Takeuchi A., Miwa S., Odani A., Tsuchiya H.
Drug Target Strategies in Breast Cancer Treatment: Recent Developments
Mayank , Jaitak V.
ABC Transporters: Unvalidated Therapeutic Targets in Cancer and the CNS
W. Robey R., R. Massey P., Amiri-Kordestani L., E. Bates S.
Novel Therapies Against Aggressive and Recurrent Epithelial Cancers by Molecular Targeting Tumor- and Metastasis-Initiating Cells and Their Progenies
Mimeault M., Batra S.
Cyclanoline Reverses Cisplatin Resistance in Bladder Cancer Cells by Inhibiting the JAK2/STAT3 Pathway
Li L., Li C., Miao F., Chen W., Kong X., Ye R., Wang F.
Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia
Shah K., Mirza S., Desai U., Jain N., Rawal R.
NFκB Pathway and microRNA-9 and -21 are Involved in Sensitivity to the Pterocarpanquinone LQB-118 in Different CML Cell Lines
de Faria F., Bento Leal M., Bernardo P., Costa P., Maia R.
Colon Cancer Therapy: Recent Developments in Nanomedicine to Improve the Efficacy of Conventional Chemotherapeutic Drugs
Prados J., Melguizo C., Ortiz R., Perazzoli G., Cabeza L., Álvarez P., Rodriguez-Serrano F., Aranega A.
Anticancer Effects of the Organosilicon Multidrug Resistance Modulator SILA 421
Olszewski U., Zeillinger R., Demirel Kars M., Zalatnai A., Molnar J., Hamilton G.
Pharmacogenomics of Human ABC Transporter ABCC11 (MRP8): Potential Risk of Breast Cancer and Chemotherapy Failure
Toyoda Y., Ishikawa T.
Quercetin’s Potential Therapeutic Role in Human Colorectal Cancer: An Effective Strategy for Prevention and Treatment
Mehrabadi S.
The Role of Serine Protease 8 in Mediating Gefitinib Resistance in Non-small Cell Lung Cancer
Gao H., Geng X., Wang L., Zhao C., Liang Z., Xing E.
Generation of Redox Imbalance Mediates the Cytotoxic Effect of Malabaricone-A in a Multidrug Resistant Cell Line
Manna A., Bauri A., Chattopadhyay S., Chatterjee M.
Using Cytochalasins to Improve Current Chemotherapeutic Approaches
Trendowski M.
Endocrine Therapy Resistance: Current Status, Possible Mechanisms and Overcoming Strategies
Chang J., Fan W.
Pharmacologic Inhibition of mTOR Improves Lapatinib Sensitivity in HER2-Overexpressing Breast Cancer Cells with Primary Trastuzumab Resistance
S. Gayle S., L.M. Arnold S., M. O'Regan R., Nahta R.
The Interactions of Anti-Cancer Drugs Approved in the Last Decade in the United States with Membrane Transporters
Jain L., Abraham S., S. Shord S.
STAT3 Signaling Axis and Tamoxifen in Breast Cancer: A Promising Target for Treatment Resistance
Zamanian M.Y., Golmohammadi M., Alalak A., Kamiab Z., Obaid R., Ramírez-Coronel A., Hjazi A., Abosaooda M., Mustafa Y., Heidari M., Verma A., Nazari Y., Bazmandegan G.
The Potential Role of Non-coding RNAs in Regulating Ferroptosis in Cancer: Mechanisms and Application Prospects
Cao M., Zhang Z., Hou X., Wang X.
The Use of Anthracyclines for Therapy of CNS Tumors
Ros M., Iorio A., Lucchesi M., Stival A., Martino M., Sardi I.
Therapeutic Targeting of Malignant Glioma
Alexandru-Abrams D., Jadus M., Hsu F., Stathopoulos A., Bota D.
New Insight into P-Glycoprotein as a Drug Target
Breier A., Gibalova L., Seres M., Barancik M., Sulova Z.
Sphingolipid Metabolism and Drug Resistance in Hematological Malignancies
Gouaze-Andersson V., C. Cabot M.
Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
Tavakoli J., B. Aragon-Ching J.
Proteomics Analysis Revealed Smad3 as a Potential Target of the Synergistic Antitumor Activity of Disulfiram and Cisplatin in Ovarian Cancer
Du R., Sun F., Li K., Qi J., Zhong W., Wang W., Sun Q., Deng Q., Wang H., Nie J., Ding C., Hong B.
Evaluation of Novel Benzo-annelated 1,4-dihydropyridines as MDR Modulators in Cancer Cells
Werner P., Szemerédi N., Spengler G., Hilgeroth A.
1 - 56 of 56 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"